Advanced Medical Solutions Group Share News (AMS)

Advanced Medical Solutions Group PLC - Cheshire, England-based developer and maker of tissue-healing technology - Says 2022 revenue and profit will be in line with market expectations, as both business units - Surgical and Woundcare - "perform well". In 2021, Advanced Medical Solutions recorded pretax profit of GBP22.0 million on revenue of GBP108.6 million. For the first half of 2022, these were GBP12.3 million and GBP58.3 million, respectively. Results for all of 2022 will be posted on March 15.

Says that over two-thirds of the patients have been recruited for the initial European Seal-G clinical trial, which is on track for completion in the first half of this year. "The underlying momentum throughout the group, which has been further strengthened with promising new products, gives us confidence of meeting market expectations for 2023 and sustaining our growth profile in the long term," says Chief Executive Officer Chris Meredith.

Current stock price: 266.43 pence, up 0.5%

12-month change: down 14%

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.